Facebook tracking pixelSchizoaffective Disorder, Depressed Type - AI-Powered ICD-10 Documentation
F25.1
ICD-10-CM
Schizoaffective Disorder, Depressed Type

Find comprehensive information on Schizoaffective Disorder, Depressed Type, including diagnostic criteria, DSM-5 codes (295.70 F25.1), ICD-10 codes (F25.1), clinical documentation best practices, differential diagnosis considerations, and treatment resources for healthcare professionals. Learn about the symptoms, prognosis, and management of this condition to improve patient care and ensure accurate medical coding and billing. Explore resources for mental health clinicians focusing on schizoaffective disorder depressed type, major depressive episodes with psychotic features, and the impact of mood disturbances on schizophrenia spectrum disorders.

Also known as

Schizoaffective Disorder, Depressive Type
Schizoaffective Disorder with Depression

Diagnosis Snapshot

Key Facts
  • Definition : Mental disorder with schizophrenia symptoms (hallucinations, delusions) and a major depressive episode.
  • Clinical Signs : Low mood, loss of interest, psychosis, social withdrawal, sleep disturbances, impaired thinking.
  • Common Settings : Outpatient clinics, inpatient hospitals, partial hospitalization programs, community mental health centers.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC F25.1 Coding
F25

Schizoaffective disorders

Mental disorders with both schizophrenic and mood symptoms.

F30-F39

Mood affective disorders

Conditions characterized by abnormalities of mood like depression.

F20-F29

Schizophrenia, schizotypal, delusional

Group of psychotic disorders affecting thoughts, perceptions, and behavior.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Primary diagnosis: Schizoaffective Disorder?

  • Yes

    Predominant mood episode: Depressed?

  • No

    Do NOT code as Schizoaffective Disorder. Review diagnostic criteria and consider alternative diagnoses.

Code Comparison

Related Codes Comparison

When to use each related code

Description
Schizoaffective, Depressed Type
Major Depressive Disorder with Psychotic Features
Schizophrenia

Documentation Best Practices

Documentation Checklist
  • Schizoaffective disorder depressed type ICD-10 F25.1 documentation
  • Major depressive episode concurrent with schizophrenia criteria
  • Delusions/hallucinations 2+ weeks without mood episode
  • Depressed mood majority of total illness duration
  • Document medical necessity for treatment/services

Mitigation Tips

Best Practices
  • ICD-10 F25.x, DSM-5 295.70: Comprehensive HPI crucial for accurate diagnosis.
  • Document symptom duration, severity for Depressed Type vs. Major Depression.
  • Rule out mood disorders, psychotic disorders: detailed medical history review.
  • CDI: Query physician for symptom clarification, medication response for specificity.
  • Medication adherence, therapy notes essential for compliance, optimized outcomes.

Clinical Decision Support

Checklist
  • 1. Verify DSM-5 criteria: Depressed mood + psychosis.
  • 2. Delusion/hallucination 2+ weeks WITHOUT mood episode.
  • 3. Prominent mood symptoms present for majority of illness.
  • 4. Rule out medical/substance-induced psychosis.
  • 5. Document symptom duration, severity, and impact.

Reimbursement and Quality Metrics

Impact Summary
  • Schizoaffective Disorder Depressed Type reimbursement hinges on accurate ICD-10-CM coding (F25.x) and reporting for optimal payer reimbursement.
  • Coding quality directly impacts Schizoaffective Disorder claims. Correctly specifying depressive type (F25.1) ensures appropriate payment.
  • Hospital quality reporting on Schizoaffective Disorder (Depressed Type) influences public perception, pay-for-performance incentives, and resource allocation.
  • Accurate documentation of depressive features, psychotic symptoms, and functional impact is crucial for Schizoaffective Disorder reimbursement and quality metrics.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code F25.1 first
  • Document psychosis duration
  • Specify major depressive episode
  • Confirm diagnostic criteria DSM5
  • Exclude substanceinduced psychosis

Documentation Templates

Patient presents with a primary diagnosis of Schizoaffective Disorder, Depressed Type (F25.1), based on DSM-5 criteria and clinical presentation.  The patient reports persistent depressed mood, meeting criteria for a major depressive episode concurrent with psychotic symptoms.  These psychotic symptoms include auditory hallucinations, specifically derogatory voices, and delusions of persecution, believing they are being monitored by an unknown entity.  These symptoms are present even in the absence of a major mood episode, fulfilling the diagnostic requirement for Schizoaffective Disorder.  Differential diagnoses considered included Major Depressive Disorder with Psychotic Features, Bipolar Disorder with Psychotic Features, and Schizophrenia.  These were ruled out based on the longitudinal course of illness and the presence of psychotic symptoms independent of mood episodes.  Current symptoms significantly impact the patient's functioning in social and occupational domains, resulting in social withdrawal and difficulty maintaining employment.  Treatment plan includes initiation of Risperidone for management of psychotic symptoms and Sertraline to address the depressive component.  Patient education regarding medication management, potential side effects, and the importance of adherence was provided.  Referral to individual psychotherapy and a support group for individuals with Schizoaffective Disorder is recommended to address coping skills, social support, and relapse prevention.  Prognosis guarded, with continued monitoring and treatment adjustments as needed.  ICD-10 code F25.1, Schizoaffective disorder, depressive type, is documented for medical billing and coding purposes.  Follow-up appointment scheduled in two weeks to assess medication efficacy and symptom improvement.